PortfoliosLab logo
MTD vs. EW
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MTD and EW is 0.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


Performance

MTD vs. EW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mettler-Toledo International Inc. (MTD) and Edwards Lifesciences Corporation (EW). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

MTD:

36.94%

EW:

9.59%

Max Drawdown

MTD:

-2.54%

EW:

-1.90%

Current Drawdown

MTD:

-1.87%

EW:

-1.90%

Fundamentals

Market Cap

MTD:

$22.47B

EW:

$43.22B

EPS

MTD:

$40.00

EW:

$2.42

PE Ratio

MTD:

27.02

EW:

30.45

PEG Ratio

MTD:

3.14

EW:

4.11

PS Ratio

MTD:

5.87

EW:

7.83

PB Ratio

MTD:

3.98K

EW:

4.27

Total Revenue (TTM)

MTD:

$3.83B

EW:

$5.54B

Gross Profit (TTM)

MTD:

$2.29B

EW:

$4.39B

EBITDA (TTM)

MTD:

$1.20B

EW:

$1.77B

Returns By Period


MTD

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

EW

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MTD vs. EW — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MTD
The Risk-Adjusted Performance Rank of MTD is 3030
Overall Rank
The Sharpe Ratio Rank of MTD is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of MTD is 2828
Sortino Ratio Rank
The Omega Ratio Rank of MTD is 2929
Omega Ratio Rank
The Calmar Ratio Rank of MTD is 3232
Calmar Ratio Rank
The Martin Ratio Rank of MTD is 3333
Martin Ratio Rank

EW
The Risk-Adjusted Performance Rank of EW is 3434
Overall Rank
The Sharpe Ratio Rank of EW is 3030
Sharpe Ratio Rank
The Sortino Ratio Rank of EW is 3232
Sortino Ratio Rank
The Omega Ratio Rank of EW is 3030
Omega Ratio Rank
The Calmar Ratio Rank of EW is 3636
Calmar Ratio Rank
The Martin Ratio Rank of EW is 3939
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MTD vs. EW - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Mettler-Toledo International Inc. (MTD) and Edwards Lifesciences Corporation (EW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

MTD vs. EW - Dividend Comparison

Neither MTD nor EW has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MTD vs. EW - Drawdown Comparison

The maximum MTD drawdown since its inception was -2.54%, which is greater than EW's maximum drawdown of -1.90%. Use the drawdown chart below to compare losses from any high point for MTD and EW. For additional features, visit the drawdowns tool.


Loading data...

Volatility

MTD vs. EW - Volatility Comparison


Loading data...

Financials

MTD vs. EW - Financials Comparison

This section allows you to compare key financial metrics between Mettler-Toledo International Inc. and Edwards Lifesciences Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


600.00M800.00M1.00B1.20B1.40B1.60B20212022202320242025
883.74M
1.41B
(MTD) Total Revenue
(EW) Total Revenue
Values in USD except per share items

MTD vs. EW - Profitability Comparison

The chart below illustrates the profitability comparison between Mettler-Toledo International Inc. and Edwards Lifesciences Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%80.0%20212022202320242025
59.5%
78.8%
(MTD) Gross Margin
(EW) Gross Margin
MTD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a gross profit of 525.88M and revenue of 883.74M. Therefore, the gross margin over that period was 59.5%.

EW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a gross profit of 1.11B and revenue of 1.41B. Therefore, the gross margin over that period was 78.8%.

MTD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported an operating income of 236.73M and revenue of 883.74M, resulting in an operating margin of 26.8%.

EW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported an operating income of 409.90M and revenue of 1.41B, resulting in an operating margin of 29.0%.

MTD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Mettler-Toledo International Inc. reported a net income of 163.59M and revenue of 883.74M, resulting in a net margin of 18.5%.

EW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Edwards Lifesciences Corporation reported a net income of 358.00M and revenue of 1.41B, resulting in a net margin of 25.3%.